Expression of Vascular Endothelial Growth Factor in Aortocoronary Saphenous Vein Bypass Grafts

Vascular

Volumn 9, Issue 5, 2001, Pages 492-498

  Bobryshev, Y V ^a   Farnsworth, A E ^b   Lord, R S A ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

Author keywords

aortocoronary saphenous vein bypass grafts; intimal neovascularisation; vascular endothelial growth factor (VEGF)

Indexed keywords

CD68 ANTIGEN; VASCULOTROPIN;

ADULT; AGED; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROTIC PLAQUE; CELL FUNCTION; CLINICAL ARTICLE; CORONARY ARTERY BYPASS GRAFT; DISEASE ASSOCIATION; ENDOTHELIUM CELL; EXPLANT; FEMALE; FOAM CELL; GRAFT OCCLUSION; HUMAN; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MALE; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; PROTEIN EXPRESSION; SAPHENOUS VEIN; STENOSIS; THROMBOSIS; THROMBUS;

AGED; ARTERIOSCLEROSIS; CORONARY ARTERY BYPASS; ENDOTHELIAL GROWTH FACTORS; FEMALE; GRAFT OCCLUSION, VASCULAR; HUMANS; LYMPHOKINES; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; SAPHENOUS VEIN; TUNICA INTIMA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0034905765     PISSN: 17085381     EISSN: None     Source Type: Journal    
DOI: 10.1177/096721090100900515     Document Type: Article

References (46)

1. Motwani, J. G. and Topol, E. J. Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention. Circulation, 1998, 97, 916-931.
2. Nielsen, T. G. Laursen, H. Gronholdt, M. L. et al. Histopathological features of in situ vein bypass stenoses. European Journal of Vascular and Endovascular Surgery, 1997, 14, 492-498.
3. Cherian, S. M. Bobryshev, V. V. Inder, S. J. et al. Involvement of dendritic cells in long term aortocoronary saphenous vein bypass graft failure. Cardiovascular Surgery, 1999, 7, 508-518.
4. Wang, A. Y. Bobryshev, Y. V. Cherian, S.M. et al. Expression of apoptosis-related proteins and structural features of cell death in explanted aortocoronary saphenous vein bypass grafts. Cardiovascular Surgery, 2001, in press.
5. O'Brien, K. D. Allen, M. D. McDonald, T. O. et al. Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques: implications for the mode of progression of advanced coronary atherosclerosis. Journal of Clinical Investigation, 1993, 92, 945-951.
6. Zhang, Y. Cliff, W. J. Schoefl, G. I. et al. Immunohistochemical study of intimal microvessels in coronary atherosclerosis. American Journal of Pathology, 1993, 143, 164-172.
7. O'Brien, E. R. Garvin, M. R. Dev, R. et al. Angiogenesis in human coronary atherosclerotic plaques. American Journal of Pathology, 1994, 145, 883-894.
8. Ignatescu, M. C. Gharehbaghi-Schnell, E. Hassan, A. et al. Expression of the angiogenic protein, platelet-derived endothelial cell growth factor, in coronary atherosclerotic plaques: In vivo correlation of lesional microvessel density and constructive vascular remodeling. Arteriosclerosis, Thrombosis and Vascular Biology, 1999, 19, 2340-2347.
9. O'Brien, K. D. McDonald, T. O. Chait, A. et al. Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content. Circulation, 1996, 93, 672-682.
10. Bobryshev, Y. V. Cherian, S. M. and Inder, S. J. Neovascular expression of VE-cadherin in human atherosclerotic arteries and its relation to intimal inflammation. Cardiovascular Research, 1999, 43, 1003-1017.
11. Barger, A. C. Beeuwkes, R. Lainey, L. L. et al. Hypothesis: vasa vasorum and neovascularization of human coronary arteries: a possible role in the pathophysiology of atherosclerosis. New England Journal of Medicine, 1984, 310, 175-177.
12. Kumamoto, M. Nakashima, Y. and Sueishi, K. Intimal neovascularization in human coronary atherosclerosis: its origin and pathophysiological significance. Human Pathology, 1995, 26, 450-456.
13. Buja, L. M. and Willerson, J. T. Role of inflammation in coronary plaque disruption. Circulation, 1994, 89, 503-505.
14. de Boer, O. J. van der Wal, A. C. Teeling, P. et al. Leukocyte recruitment in rupture prone regions of lipid-rich plaques: a prominent role for neovascularization? Cardiovascular Research, 1999, 41, 443-449.
15. van der Wal, A. C. and Becker, A. E. Atherosclerotic plaque rupture-pathologic basis of plaque stability and instability. Cardiovascular Research, 1999, 41, 334-344.
16. Couffinhal, T. Kearney, M. Witzenbichler, B. et al. Vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in normal and atherosclerotic human arteries. American Journal of Pathology, 1997, 150, 1673-1685.
17. Inoue, M. Itoh, H. Ueda, M. et al. Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: Possible pathophysiological significance of VEGF in progression of atherosclerosis. Circulation, 1998, 98, 2108-2116.
18. Chen, Y. X. Nakashima, Y. Tanaka, K. et al. Immunohistochemical expression of vascular endothelial growth factor/vascular permeability factor in atherosclerotic intimas of human coronary arteries. Arteriosclerosis, Thrombosis and Vascular Biology, 1999, 19, 131-139.
19. Klagsbrun, M. and D'Amore, P. A. Vascular endothelial growth factor and its receptors. Cytokine and Growth Factor Review, 1996, 7, 259-270.
20. Stephan, C. C. and Brock, T. A. Vascular endothelial growth factor, a multifunctional polypeptide. P.R. Health Science Journal, 1996, 15, 169-178.
21. Dvorak, H. F. Brown, L. F. Detmar, M. et al. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. American Journal of Pathology, 1995, 146, 1029-1039.
22. Senger, D. R. Claffey, K. P. Benes, J. E. et al. Angiogenesis promoted by vascular endothelial growth factor: regulation through 1ß1 integrins. Proceedings of National Academy of Science USA, 1997, 94, 13612-13617.
23. Pepper, M. S. Ferrara, N. Orci, L. et al. Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochemical and Biophysical Research Communications, 1991, 181, 902-906.
24. Ferrara, N. and Davis-Smyth, T. The biology of vascular endothelial growth factor. Endocrinology Review, 1997, 18, 4-25.
25. Clauss, M. Weich, H. Breier, G. et al. The vascular endothelial growth factor receptor Flt-1 mediates biological activities: implications for a functional role of placenta growth factor in monocyte activation and chemotaxis. Journal of Biological Chemistry, 1996, 271, 17629-17634.
26. Barleon, B. Sozzani, S. Zhou, D. et al. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood, 1996, 87, 3336-3343.
27. British Medical Council: Human Experimentation, Code of ethics of the World Medical Association and statement on responsibility in investigations on human subjects. British Medical Journal, 1964, 2, 177-180.
28. Hsu, S.-M. Raine, L. and Fanger, H. Use of avidin-biotin—peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. Journal of Histochemestry and Cytochemistry, 1981, 29, 577-580.
29. Colville-Nash, P. R. and Willoughby, D. A. Growth factors in angiogenesis: current interest and therapeutic potential. Molecular Medicine Today, 1997, 3, 14-23.
30. Breier, G. Damert, A. Plate, K. H. et al. Angiogenesis in embryos and ischemic diseases. Thrombosis and Haemostasis, 1997, 78, 678-683.
31. Shalaby, F. Rossant, J. Yamaguchi, T. P. et al. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature, 1995, 376, 62-66.
32. Hanahan, D. and Folkman, J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell, 1996, 86, 353-364.
33. Appleton, I. Brown, N. J. Willis, D. et al. The role of vascular endothelial growth factor in a murine chronic granulomatous tissue air pouch model of angiogenesis. Journal of Pathology, 1996, 180, 90-94.
34. Hata, Y. Nakagawa, K. Ishibashi, T. et al. Hypoxia-induced expression of vascular endothelial growth factor by retinal glial cells promotes in vitro angiogenesis. Virchows Archives, 1995, 426, 479-486.
35. Shweiki, D. Itin, A. Soffer, D. et al. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature, 1992, 359, 843-845.
36. Stavri, G. T. Zachary, I. C. Baskerville, P. A. et al. Basic fibroblast growth factor upregulates the expression of vascular endothelial growth factor in vascular smooth muscle cells: synergistic interaction with hypoxia. Circulation, 1995, 92, 11-14.
37. Stavri, G. T. Hong, Y. Zachary, I. C. et al. Hypoxia and platelet-derived growth factor-BB synergistically upregulate the expression of vascular endothelial growth factor in vascular smooth muscle cells. FEBS Letters, 1995, 358, 311-315.
38. Pertovaara, L. Kaipainen, A. Mustonen, T. et al. Vascular endothelial growth factor is induced in response to transforming growth factor-ß in fibroblastic and epithelial cells. Journal of Biological Chemistry, 1994, 269, 6271-6274.
39. Jackson, J. R. Minton, J. A. Ho, M. L. et al. Expression of vascular endothelial growth factor in synovial fibroblasts is induced by hypoxia and interleukin 1ß. Journal of Rheumatology, 1997, 24, 1253-1259.
40. Ross, R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature, 1993, 362, 801-809.
41. Silins, G. Grimmond, S. Egerton, M. et al. Analysis of the promoter region of the human VEGF-related factor gene. Biochemical and Biophysical Research Communications, 1997, 230, 413-418.
42. Liu, Y. Cox, S. R. Morita, T. et al. Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells: identification of a 5′ enhancer. Circulation Research, 1995, 77, 638-643.
43. Minchenko, A. Salceda, S. Bauer, T. et al. Hypoxia regulatory elements of the human vascular endothelial growth factor gene. Cell and Molecular Biology Research, 1994, 40, 35-39.
44. Damert, A. Ikeda, E. and Risau, W. Activator-protein-1 binding potentiates the hypoxia-inducible factor-1-mediated hypoxia-induced transcriptional activation of vascular-endothelial growth factor expression in C6 glioma cells. Biochemical Journal, 1997, 327, 419-423.
45. Ryuto, M. Ono, M. Izumi, H. et al. Induction of vascular endothelial growth factor by tumor necrosis factor in human glioma cells: possible roles of SP-1. Journal of Biological Chemistry, 1996, 271, 28220-28228.
46. Bjornheden, T. Evaldsson, M. and Wiklund, O. A method for the assessment of hypoxia in the arterial wall, with potential application in vivo. Arteriosclerosis, Thrombosis and Vascular Biology, 1996, 16, 178-185.